Immune System News and Research

RSS

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

A new study by iData Research estimates that there are nearly 150,000 new cases of psoriasis every year in the United States, affecting 2.2% of the population.

20 Jun 2018

Researchers use advanced technology to identify proteomes of Th17 and iTreg cells

T helper 17 (Th17) cells belong to a group of T cells with essential functions in autoimmune diseases and inflammation. Regulatory T cells (iTregs) are T cells with a suppressive function to maintain self-tolerance and prevent autoimmune responses.

20 Jun 2018

Monash study reveals why older people have reduced immune responses to cancer therapy

It's called the Silver Tsunami - the increased incidence of cancer with aging, combined with the rapidly aging population means that the Australian health system needs to prepare for an onslaught of cancer diagnoses.

20 Jun 2018

Study provides new insight on how antibiotics affect the gut microbiome

New insight on how antibiotics affect the gut microbiome - the community of microbes that live inside us - has been published in the journal eLife.

19 Jun 2018

Scientists discover new mechanism controlling multiple sclerosis risk

While the DNA sequence remains the same throughout a person's life, the expression of the encoded genes may change with time and contribute to disease development in genetically predisposed individuals.

19 Jun 2018

Low blood levels of vitamin D linked to increased risk of interstitial lung disease

Reviewing medical information gathered on more than 6,000 adults over a 10-year period, Johns Hopkins researchers have found that lower than normal blood levels of vitamin D were linked to increased risk of early signs of interstitial lung disease.

19 Jun 2018

Clinical trial targets metastatic colorectal cancer with new combination therapy

Rutgers Cancer Institute of New Jersey is offering a clinical trial targeting an advanced form of colorectal cancer with a combination vaccine/immunotherapy drug treatment.

19 Jun 2018

Study: Rheumatoid Arthritis patients with depression have increased risk of disease flare

Research from the Department of Inflammation Biology, School of Immunology & Microbial Sciences has shown there is an increased risk of disease flare in Rheumatoid Arthritis patients who suffer from depression.

19 Jun 2018

CytoReason builds largest reference of immune-focused inter-cellular communications

New data published in Nature Biotechnology, represents the largest ever analysis of immune cell signaling research, mapping more than 3,000 previously unlisted cellular interactions, and yielding the first ever immune-centric modular classification of diseases.

19 Jun 2018

Researchers use droplet-sized 'miniecosystems' to test therapeutic potential of molecules

Scripps Research scientists have solved a major problem in chemistry and drug development by using droplet-sized 'miniecosystems' to quickly see if a molecule can function as a potential therapeutic.

19 Jun 2018

Researchers discover new defense mechanism against oxygen radicals

Oxygen radicals occur as a by-product when living beings burn carbohydrates or fat. They are suspected of accelerating the ageing process in humans and animals, and to be partly responsible for severe illnesses such as Alzheimer's or certain types of cancer.

18 Jun 2018

Study finds increased risk of mortality in people with cold agglutinin disease in five years after diagnosis

Bioverativ Inc., a Sanofi company dedicated to transforming the lives of people with rare blood disorders, today announced results from a new, population-based retrospective study that found a greater than twofold increased risk of mortality in people with cold agglutinin disease within the first five years after diagnosis.

18 Jun 2018

Innovative drugs and new European treatment guidelines refine, improve MS therapy

MS is the most common neurological disease in young adults. There are about 2.3 million people worldwide who face a high risk of ever worsening disabilities from this disease.

18 Jun 2018

Studies provide insight into molecular changes prior to onset of arthritis

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR 2018) provide insight into molecular changes prior to the onset of arthritis which could inform future novel diagnostics and early therapeutic interventions.

18 Jun 2018

Award granted to Neem Biotech to develop antimicrobial intervention for chronic lung infections

Neem are working on a novel approach to antimicrobial resistance, which involves preventing the formation of and disrupts mature biofilms that are produced by bacteria such as Pseudomonas aeruginosa and Staphylococcus aureus.

From Neem Biotech 18 Jun 2018

New study highlights predictors that prevent from achieving remission in early RA

The results of a study presented today at the Annual European Congress of Rheumatology report that obesity in women and current smoking in men were the strongest predictors of not achieving remission in early rheumatoid arthritis within a year.

18 Jun 2018

Study demonstrates increased levels of gum disease in people at risk of rheumatoid arthritis

The results of a study presented at the Annual European Congress of Rheumatology demonstrates increased levels of gum disease, and disease-causing bacteria, in individuals at risk of rheumatoid arthritis.

18 Jun 2018

New studies help elucidate role of sleep in chronic pain

The results of two studies presented today at the Annual European Congress of Rheumatology provide insight into the role of sleep in chronic pain.

18 Jun 2018

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

The results of an open label extension of a phase II study presented today at the Annual European Congress of Rheumatology, 2018, demonstrate that lenabasum continues to have acceptable safety and tolerability in diffuse cutaneous systemic sclerosis with no severe or serious adverse events.

18 Jun 2018

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate that canakinumab significantly reduced the rate of gout by more than half compared to placebo, regardless of baseline serum urate level.

18 Jun 2018

Immune System News and Research

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

Researchers use advanced technology to identify proteomes of Th17 and iTreg cells

Monash study reveals why older people have reduced immune responses to cancer therapy

Study provides new insight on how antibiotics affect the gut microbiome

Scientists discover new mechanism controlling multiple sclerosis risk

Low blood levels of vitamin D linked to increased risk of interstitial lung disease

Clinical trial targets metastatic colorectal cancer with new combination therapy

Study: Rheumatoid Arthritis patients with depression have increased risk of disease flare

CytoReason builds largest reference of immune-focused inter-cellular communications

Researchers use droplet-sized 'miniecosystems' to test therapeutic potential of molecules

Researchers discover new defense mechanism against oxygen radicals

Study finds increased risk of mortality in people with cold agglutinin disease in five years after diagnosis

Innovative drugs and new European treatment guidelines refine, improve MS therapy

Studies provide insight into molecular changes prior to onset of arthritis

Award granted to Neem Biotech to develop antimicrobial intervention for chronic lung infections

New study highlights predictors that prevent from achieving remission in early RA

Study demonstrates increased levels of gum disease in people at risk of rheumatoid arthritis

New studies help elucidate role of sleep in chronic pain

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

Understanding the DNA Damage Response in Innate Immunity eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News